Free Radicals and Lipid Signaling in Endothelial Cells

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Antioxidants and Redox Signaling

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1089/152308603764816550PMID 12716479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reactive Oxygen Species as Downstream Mediators of Angiogenic Signaling by Vascular Endothelial Growth Factor Receptor-2/KDR*

  2002cited by this paper
• A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid.

  2002cited by this paper
• Expression of 5-lipoxygenase in pulmonary artery endothelial cells.

  2002cited by this paper
• 5-Lipoxygenase and human pulmonary artery endothelial cell proliferation.

  2002cited by this paper
• Regulation of eNOS Expression in Brain Endothelial Cells by Perinuclear EP3 Receptors

  2002cited by this paper
• Roles of Cyclooxygenase (COX)-1 and COX-2 in Prostanoid Production by Human Endothelial Cells: Selective Up-Regulation of Prostacyclin Synthesis by COX-21

  2001influential reference
• PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways.

  2001cited by this paper
• Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2.

  2001cited by this paper
• Biphasic Effects of 15-Deoxy-&Dgr;12,14-Prostaglandin J2 on Glutathione Induction and Apoptosis in Human Endothelial Cells

  2001cited by this paper
• Tumor Necrosis Factor-α Induces Cyclooxygenase-2 Expression and Prostaglandin Release in Brain Microvessel Endothelial Cells

  2001cited by this paper
• 12-lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation.

  2001cited by this paper
• Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor.

  2001cited by this paper
• PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.

  2001cited by this paper
• Interleukin 4 induces transcription of the 15-lipoxygenase I gene in human endothelial cells.

  2001influential reference
• NO regulates LPS-stimulated cyclooxygenase gene expression and activity in pulmonary artery endothelium.

  2001cited by this paper
• Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner.

  2001cited by this paper
• Adenoviral Delivery of a Leukocyte-Type 12 Lipoxygenase Ribozyme Inhibits Effects of Glucose and Platelet-Derived Growth Factor in Vascular Endothelial and Smooth Muscle Cells

  2001cited by this paper
• Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells.

  2001cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Activators Inhibit IFN-γ-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells1

  2000cited by this paper
• Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase.

  2000cited by this paper
• Involvement of Phospholipid Hydroperoxide Glutathione Peroxidase in the Modulation of Prostaglandin D2 Synthesis*

  2000cited by this paper
• In Situ Amplification of 5-Lipoxygenase and 5-Lipoxygenase-Activating Protein in Allergic Airway Inflammation and Inhibition by Leukotriene Blockade1

  2000cited by this paper
• Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.

  2000cited by this paper
• Catalytic Consumption of Nitric Oxide by Prostaglandin H Synthase-1 Regulates Platelet Function*

  2000cited by this paper
• Prostaglandin E2 induces expression of P-selectin (CD62P) on cultured human umbilical vein endothelial cells and enhances endothelial binding of CD4-T-cells.

  2000cited by this paper
• Inhibition by Extracellular cAMP of Phorbol 12-Myristate 13-Acetate-induced Prostaglandin H Synthase-2 Expression in Human Pulmonary Microvascular Endothelial Cells

  2000cited by this paper
• Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.

  2000cited by this paper
• Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries.

  2000cited by this paper
• Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

  1999cited by this paper
• Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

  1999cited by this paper
• Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites.

  1999cited by this paper
• Basic fibroblast growth factor induces cyclooxygenase-2 expression in endothelial cells derived from bone.

  1999cited by this paper
• Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.

  1999cited by this paper
• Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction.

  1999cited by this paper
• Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

  1999cited by this paper
• Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.

  1999cited by this paper
• Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2 *

  1999cited by this paper
• Developmental regulation of endothelial nitric oxide synthase in cerebral vessels of newborn pig by prostaglandin E(2).

  1999cited by this paper
• 15-Lipoxygenase Catalytically Consumes Nitric Oxide and Impairs Activation of Guanylate Cyclase*

  1999cited by this paper
• PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease.

  1999cited by this paper
• 12-Lipoxygenase products increase monocyte:endothelial interactions.

  1999cited by this paper
• Identification of a lipoxygenase inhibitor in A431 cells as a phospholipid hydroperoxide glutathione peroxidase

  1998cited by this paper
• 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.

  1998cited by this paper
• Selective cyclooxygenase-2 inhibition by nimesulide in man.

  1998cited by this paper
• Nitric Oxide Trapping of Tyrosyl Radicals Generated during Prostaglandin Endoperoxide Synthase Turnover

  1998cited by this paper
• Subcellular Localization of Prostaglandin Endoperoxide H Synthases-1 and -2 by Immunoelectron Microscopy*

  1998cited by this paper
• Structural Characterization of Arachidonyl Radicals Formed by Prostaglandin H Synthase-2 and Prostaglandin H Synthase-1 Reconstituted with Mangano Protoporphyrin IX*

  1998cited by this paper
• Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium.

  1998cited by this paper
• Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth.

  1998cited by this paper
• Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages.

  1997cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1997cited by this paper
• Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2.

  1997influential reference
• Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.

  1997cited by this paper
• Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells*

  1997cited by this paper
• Mutational Analysis of the Role of the Distal Histidine and Glutamine Residues of Prostaglandin-Endoperoxide Synthase-2 in Peroxidase Catalysis, Hydroperoxide Reduction, and Cyclooxygenase Activation*

  1997cited by this paper
• In Vivo Formation of 8-Epi-Prostaglandin F2α Is Increased in Hypercholesterolemia

  1997cited by this paper
• In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

  1997cited by this paper
• Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

  1996cited by this paper
• Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450

  1996cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1996cited by this paper
• Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.

  1996cited by this paper
• Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.

  1996cited by this paper
• Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

  1996cited by this paper
• Nitric oxide enhances cyclooxygenase activity in articular cartilage

  1996cited by this paper
• Nitric oxide: a prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages.

  1996cited by this paper
• Interferon‐γ and Nitric Oxide Down‐Regulate Lipopolysaccharide‐Induced Prostanoid Production in Cultured Rat Microglial Cells by Inhibiting Cyclooxygenase‐2 Expression

  1996cited by this paper
• Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells.

  1996cited by this paper
• Cyclooxygenases-1 and −2 of Endothelial Cells Utilize Exogenous or Endogenous Arachidonic Acid for Transcellular Production of Thromboxane (*)

  1996cited by this paper
• Prostaglandin endoperoxide H synthases-1 and -2.

  1996cited by this paper
• 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis.

  1995cited by this paper
• Lipoxygenase-mediated glutathione oxidation and superoxide generation.

  1995cited by this paper
• Interleukin-1 Enhances the Ability of Cultured Human Umbilical Vein Endothelial Cells to Oxidize Linoleic Acid (*)

  1995cited by this paper
• Transcriptional activation of endothelial cell integrin alpha v by protein kinase C activator 12(S)-HETE.

  1995cited by this paper
• Cytochrome P450 mono‐oxygenase‐regulated signalling of Ca2+ entry in human and bovine endothelial cells.

  1995cited by this paper
• Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase.

  1995cited by this paper
• Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.

  1995cited by this paper
• Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.

  1994cited by this paper
• Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression.

  1994cited by this paper
• Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.

  1994cited by this paper
• Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation.

  1994cited by this paper
• Involvement of 15-lipoxygenase in early stages of atherogenesis

  1994cited by this paper
• The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

  1994cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper
• Selective inhibition of the 12-lipoxygenase pathway of arachidonic acid metabolism by L-arginine or sodium nitroprusside in intact human platelets.

  1994influential reference
• Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

  1994cited by this paper
• Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

  1994cited by this paper
• Nitric oxide activates cyclooxygenase enzymes.

  1993cited by this paper
• 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells.

  1993cited by this paper
• Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin‐6 by rat Kupffer cells

  1993influential reference
• Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid.

  1993cited by this paper
• A cryptic, microsomal-type arachidonate 12-lipoxygenase is tonically inactivated by oxidation-reduction conditions in cultured epithelial cells.

  1993cited by this paper
• Increased Thromboxane Biosynthesis in Type IIa Hypercholesterolemia

  1992cited by this paper
• Cytochrome P450 and the arachidonate cascade 1

  1992cited by this paper
• Characterization of human 12-lipoxygenase genes.

  1992cited by this paper
• Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation.

  1992cited by this paper
• Induction of heme oxygenase by Δ12-prostaglandin J2 in porcine aortic endothelial cells

  1992cited by this paper
• Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells.

  1992cited by this paper
• Determination of 134Cs in environmental samples using a coincidence gamma-ray spectrometer

  1991cited by this paper
• Estrogen and coronary heart disease in women

  1991cited by this paper
• Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

  1991cited by this paper

• Elevated phospholipid hydroperoxide glutathione peroxidase (GPX4) expression modulates oxylipin formation and inhibits age-related skeletal muscle atrophy and weakness

  2023cites this paper
• The metabolic engine of endothelial cells

  2019cites this paper
• The metabolic engine of endothelial cells

  2019cites this paper
• Hypertension and Dyslipidemia among Type II Diabetic Patients and Related Risk Factors and Complications

  2018cites this paper
• Detection of Left Atrial Enlargement by Echocardiography and Electrocardiogram Correlation in Cardiac and Non-cardiac Diseases

  2016cites this paper
• Cardiometabolic risk factors in bank employees

  2015cites this paper
• Electrochemical, Mass Spectroscopic, Immunochemical, and Nuclear Magnetic Resonance Techniques

  2015cites this paper
• Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.

  2015cites this paper
• Functional characterization of genetic enzyme variations in human lipoxygenases

  2013cites this paper
• Animal and Cellular Models for Use in Nanoparticles Safety Study

  2013cites this paper
• A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol

  2012cites this paper
• Cyclooxygenase-2: Biology of Prostanoid Biosynthesis and Metabolism

  2012cites this paper
• LIPITENSION: Interplay between dyslipidemia and hypertension

  2012cites this paper
• Ezetimibe and reactive oxygen species.

  2011cites this paper
• Oxidants and Endothelial Dysfunction

  2010cites this paper
• Selenium inhibits 15-hydroperoxyoctadecadienoic acid-induced intracellular adhesion molecule expression in aortic endothelial cells.

  2008influential citation
• Pharmacodynamic of cyclooxygenase inhibitors in humans.

  2007cites this paper
• Atherosclerosis Pathophysiology and the Role of Novel Risk Factors: A Clinicobiochemical Perspective

  2007cites this paper
• The case against controlled release lipoic acid:

  2007cites this paper
• The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients

  2007cites this paper
• Arachidonate and NADPH oxidase synergise with iNOS to induce death in macrophages: mechanisms of inflammatory degeneration.

  2006cites this paper
• Reversible Post-translational Modification of Proteins by Nitrated Fatty Acids in Vivo*

  2006cites this paper
• Dietary vitamin E reduces labile iron in rat tissues

  2005cites this paper
• Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy

  2005cites this paper
• Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension

  2005cites this paper
• Evidence for a combined approach to the management of hypertension and dyslipidemia.

  2005cites this paper
• The Role of Endothelial Cells in the Resolution of Acute Inflammation

  2005cites this paper
• The antioxidants and pro-antioxidants network: an overview.

  2004cites this paper
• Biological Functions and Metabolic Fate of Vitamin E Revisited

  2004cites this paper
• Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.

  2004cites this paper
• Redox Regulation of Endothelial Function

  2003cites this paper
• Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension.

  2003cites this paper
• Forum Editorial

  year unknowncites this paper